EDGAR·FLOW

ONCOLYTICS BIOTECH INC — Form 8-K

Filed November 20, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 12/100
What the filing says
Form 8-K filed 2026-11-20 (period 2026-11-19) disclosing Item 5.07 — Submission of Matters to a Vote of Security Holders. No specific vote details, counterparties, dollar amounts, percentages, share counts, or outcomes are provided in the filing header or document summary. The filing appears to be a standard procedural disclosure with substantive information not accessible from the metadata provided.
Why this rating

Routine voting disclosure; no material financial, operational, or strategic details disclosed. Insufficient information to assess business impact.

Extracted items
View original filing on SEC.gov ↗ ONCY · stock on Yahoo Finance ↗

See more from November 20, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.